LIBROS
Hesse A, Tiselius H-G, Jahnen A, eds. Urinary stones: diagnosis, treatment and prevention of recurrence. 2.a ed. Basel: Karger; 2002.
Russell G, Ralston S, Rogers MJ, eds. Bisphosphonates. Andover: Martin Dunitz; 2001.
Eastell R, Meunier P, eds. A practical guide to osteoporosis. Andover: Martin Dunitz; 2001.
NUESTROS AUTORES
Martínez G, Gómez R, Jodar E, Loinaz L, Moreno E, Hawkins F. Long-term follow-up of bone mass after orthotopic liver transplantation: Effect of steroid withdrawal from the immunosupressive regimen. Osteoporosis Int 2002;13:147-50.
Sosa M, Hernández D, Segarra MC, Gómez A, de la Pena C, Betancor P. Effect of two forms of alendronate administration upon bone mass after two years of treatment. J Clin Densitom 2002;5:27-34.
Se ruega a los autores enviar una copia del trabajo para incluir su cita en esta Sección.
REVISIONES
Turner CH. Biomechanics of bone: Determinants of skeletal fragility and bone quality. Osteoporosis Int 2002;13:97-104.
Bonewald IF. Osteocytes: a proposed multifunctional bone cell. J Musculoeskel Neuron Interact 2002;2:239-41.
Gruber CJ, Tschgguel W, Scheeberger C, Huber JC. Production and actions of strogens. N Engl J Med 2002;346:340-52.
Burr DB. Targeted and nontargeted remodeling. Bone 2002;30:2-4.
Martin RB. Is all cortical bone remodeling iniciated by microdamage? Bone 2002;30:8-13.
Parfitt AM. Misconceptions (1): Epyphyseal fusion causes cessation of growth. Bone 2002;30:337-9.
Khoska S. Estrogens, bones and men: when testosterone just is't enough. Clin Endocrinol 2002;56:291-4.
Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporosis Int 2002;13:187-94.
Stewart AF. Hyperparathyroidism, humoral hypercalcemia of malignancy and the anabolic actions of parathyroid hormone and parathormone-related protein on the skeleton. J Bone Miner Res 2002;17:758-62.
Rubin MR, Cosman F, Lindsay R, Bilezikian JP. The anabolic effects of parathyroid hormone. Bone 2002;13:267-78.
Burnett JR, Vasikaran SD. Cardiovascular disease and osteoporosis: is there a link between lipids and bone? Ann Clin Biochem 2002;39:203-10.
Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13: 187-94.
Zaidi M, Inzerillo AM, Moonga BS, Bevis PJ, Huang CL. Forty years of calcitonin-where are we now? A tribute to the work of Ian MacIntyre. Bone 2002;30:655-63.
National Consensus Conference on Improving the Continuum of Care for Patients with Hip Fracture. May 3-4, 2001, Washington, DC. Rehabil Nurs 2002;27:83-6.
Fitzpatrick LA. Secondary causes of osteoporosis. Mayo Clin Proc 2002;77:453-68.
Lark MW, James IE, Lark MW, James IE. Novel bone antiresorptive approaches. Curr Opin Pharmacol 2002;2:330-7.
Gonnelli S, Cepollaro C. The use of ultrasound in the assessment of bone status. J Endocrinol Invest 2002;25:389-97.
Einhorn. Do Inhibitors of cyclooxygenase-2 impair bone gealing? J Bone Mineral Res 2002;17:977-8.
OTROS ARTICULOS DE INTERÉS
Lee SH, Dargent-Molinaand P, Breart G, for the Epidos Group. J Bone Miner Res 2002;17:817-25.
Dhesi JK, Bearne LM, Moniz C, Hurley MV, Jackson SHD, Swift CG, Allain TJ. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002;17:891-7.
Aris RM, Ontjes DA, Buell HE, Blackwood AD, Lark RK, Caminiti M, et al. Abnormal bone turnover in cystic fibrosis adults. Osteoporosis Int 2002;13:151-7.
Warming L, Hassager C, Christiansen C. Changes in bone mineral density with age in men and women: a longitudinal study. Osteoporosis Int 2002;13:105-12.
Horiuchi T, Onouchi J, Inoue J, Shionoiri A, Hosoi T, Orimo H. A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy. Gerontology 2002;28: 103-8.
Lasco A, Morabito N, Gaudio A, Crisafuli A, Meo A, Denuzzo G, Frisina N. Osteoporosis and a-thalassemia major: Role of the IGF.I/IGFBP-III axis. J Endocrinol Invest 2002;25: 338-44.
Brumsem C, Hamdy NAT, Papapoulos SE. Osteoporosis and bone marrow mastocytosis: Dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res 2002;17:567-9.
Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. Effect of Cronh's disease on bone metabolism in vitro: A role for interleukin-6. J Bone Miner Res 2002;17:695-702.
Meyer HE, Smedshaug GB, Kvaavik E, Falch JA, Tverdal A, Pedersen JJ. Can vitamina D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002; 17:709-15.
Shepherd JA, Cheng XG, Lu Y, Njeh C, Toschke J, Engelke K, et al. Universal standarization of forearm bone densitometry. J Bone Miner Res 2002;17:734-45.
Cummings SR, Karpf DB, Harris F, Gnant HK, Ensrud K, et al. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 2002;112:281-9.
Sato Y, Nose I, Higuchi F, Higuchi F, Kondo I. Changes in the supporting muscles of the fractured hip in elderly women. Bone 2002;30:325-30.
Romas E, Gillspie MT, Martin TJ. Involvement of receptor activator of NFkB ligand and tumor necrosis factor-a in bone destruction in rheumatoid arthritis. Bone 2002;30:340-6.
Whyte MP, Reines WR, Podgornik MN, Mills BG. Familial Expansile Osteolysis (excessive RANK effect) in a 5-generation American kindred. Medicine 2002;81:101-21.
Vestergaard P, Vorgensen JOL, Hagan C, Hoeck HC, Laurberg P, Rejnmark L, et al. Fracture risk is increased in patients with GH deficiency or untreated prolactinoma a case control stufy. Clin Endocrinol 2002;56:239-46.
Speden DJ, Calin AI, Ring FJ, Bhalla AK. Bone mineral density, calcaneal ultrasound and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 2002;29:516-21.
Boonen S, Rosen C, Bouillon R, Sommer A, McKay M, Rosen D, et al. Musculoskeletal effects of the recombinant human IGF-1 IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. J Clin Endocrinol Metab 2002;1593-9.
Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, et al. Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal o secondary hyperparathyroidism and hip fracture risk. Osteoporosis Int 2002;13:257-64.
Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A. Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. Bone 2002;30:303-8.
Gabriel SE, Tosteson ANA, Leibson CL, Crowson CD, Pond GR, Hammond CS, Melton LJ. Direct medical costs attributable to osteoporostic fractures. Bone 2002;30:323-30.
Hara S, Yanagi H, Amagai H, Endoh K, Tsuchiya S, Tomura S. Effect of physical activity during teenage years, based on type of sport and duration of exercise, on bone mineral density of young, premenopausal Japanese women. Calcif Tissue Int 2001;68:23-30.
Compston JE, Watts NB. Combination therapy for postmenopausal osteoporosis. Clin Endocrinol (Oxf) 2002;56-565-9.
Giangregorio L, Blimkie CJ. Skeletal adaptations to alterations in weight-bearing activity: a comparison of models of disuse osteoporosis. Sports Med 2002;32:459-76.
Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, et al. High bone density due to a mutation in LDL-receptor-related protein 50. N Engl J Med 2002;346:1513-21.
Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
Lee SH, Dargent-Molina P, Breart G, Epidos Group. Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study. J Bone Miner Res 2002;17:817-25.
Shiomi S, Nishiguchi S, Kubo S, Tomari A, Habu D, Takeda T, Ochi H. Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol 2002;97:978-81.
Caulin F, Kanis JA, Johnell O, Oden A. Optimal age for preventing osteoporosis after menopause depends on effects ofstopping treatment. Bone 2002;30:754-8.
Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002;87:2060-6.
Baudoin C, Cohen-Solal ME, Beaudreuil J, de Vernejoul MC. Genetic and environmental factors affect bone density variances of families of men and women with osteoporosis. J Clin Endocrinol Metab 2002;87:2053-9.
Berruti A, Dogliotti L, Terrone C, Cerutti S, Isaia G, Tarabuzzi R, et al. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 2002;167:2361-7.
Juby AG, de Geus-Wenceslau CM. Evaluation of osteoporosis treatment in seniors after hip fracture. Osteoporosis Int 2002;13:205-10.
Peh WC, Gilula LA, Peck DD. Percutaneous vertebroplasty for severe osteoporotic vertebral body compression fractures. Radiology 2002;223:121-6.
Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R. The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. J Bone Miner Res 2002;17:1081-94.
Van der Klift M, de Laet CEDH, McCloskey EV, Hofman A, Pols HAP. The incidence of vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 2002;17:1051-6.